Advaxis, Inc.
Advaxis Chairman/CEO Thomas A. Moore Issues Statement
Published in Vaccine Weekly, March 3rd, 2010
"Advaxis shares will trade today with an 'e' at the end of its ticker symbol, 'ADXSE.'" This temporary ticker symbol change is due to our inability to file our annual statement in a timely manner, under the US Securities and Exchange Commission's regulations. It does not however, affect any shareholder's total share position.
"This temporary shortcoming is a product of the complex accounting required for the debt instruments we have implemented over the past nine...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2010-03-03)
More Articles from Vaccine Weekly
- Journal of the National Cancer Institute
News brief: Benefit of HPV vaccination, frequent screening for women over 41 is likely to be low - BioSante Pharmaceuticals, Inc.
BioSante Pharmaceuticals Rated Among Top 15 Companies on the Biotechnology Patent Scorecard(TM) as published in the Wall Street Journal - Gene Therapy
Studies from H. Suzuki et al add new findings in the area of gene therapy - Immunization
Data from M. Haidari et al provide new insights into immunization - Immunization
New findings from St. Lukes Hospital in the area of immunization published - Immunization
New findings in immunization described from St. Pauls Hospital - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
